Analytics cookies help us understand what works in the catalog. Accept all, reject non-essential ones, or choose categories below. Privacy policy
A second-generation "exercise mimetic": a small molecule (not a peptide) that switches on the aerobic programme in muscles — and, unlike SLU-PP-332, can be taken by mouth. It increased endurance in mice; it has not been studied in humans yet.
Size: 10 mg
No published analyses yet.
Research, properties and limitations
AI can make mistakes
Titration schedule · reference
The information below is provided from public sources for reference only. It is not advice or instructions for use; products are intended for laboratory research only and not for human consumption.
| Period / condition | Dose | Escalation |
|---|---|---|
| Start (oral) | 1 mg per day | Starting dose |
| Titration | 1–2 mg per day | Increase if needed |
| Upper reference in this schedule | up to 2–3 mg per day (may be split into 2 doses) | Maximum in this schedule |
Research overview · reference
Below is a short summary of what the authors of published studies reported. It is not medical advice or instructions for use; products are intended for laboratory research only and not for human consumption.
| Effect | Model or participants | How often or as described | Source |
|---|---|---|---|
| Clinical adverse-event frequencies | Mice, oral and intraperitoneal administration | The abstract describes endurance and molecular measurements rather than clinical adverse-event frequencies; findings about SLU-PP-332 do not transfer to this distinct molecule | [1] |
FAQ
Find answers to questions about SLU-PP-915 and related materials.
It is a small synthetic molecule — a second-generation "exercise mimetic". It switches on the ERR receptors that launch the aerobic-training programme in muscles; it was developed at Saint Louis University, in the same programme as SLU-PP-332.
Source / documentationNo. It is a small synthetic molecule with its own chemical scaffold, including a boronic-acid fragment. Peptides are chains of amino acids, and the 915 compound is not one of them, even though it sits on the same "metabolic" shelf.
Source / documentationBy chemistry and by how it is taken. The 332 compound breaks down quickly in the body, so studies gave it by injection; the 915 compound is markedly more stable and can be taken by mouth — it needs no injection. It is not a new version of the 332; it is a substance in its own right.
Source / documentationBecause it switches on the same programme in muscles as aerobic exercise: the ERR receptors shift muscles toward endurance and fuel burning. In mice, oral 915 increased running endurance about as much as injected 332.
Source / documentationBy mouth — no injection is needed. Our guide lists these regimens: start at 1 mg a day, titration at 1–2 mg, and an upper range of 2–3 mg a day, which can be split into two doses. These summarise preclinical work, not a clinical regimen. Details are in the dosing guide on this page.
Source / documentationUnknown. All published data are in mice only (Billon et al., Journal of Pharmacology and Experimental Therapeutics, 2026); there have been no human studies yet, so an effect in people is unproven.
Source / documentationThere are no data: there have been no human studies, and preclinical work in mice does not yield an honest list of side effects for people. A full review of the known data is in the SLU-PP-915 monograph in our wiki.
Source / documentationIn a dry, dark place at a low temperature. Details are in the SLU-PP-915 guide on this page.
Source / documentationYou can buy SLU-PP-915 right on this page of our store: choose a pack size; current prices and stock are shown in the product card. We deliver across Ukraine with Nova Poshta — to a branch, a parcel locker, or by courier. Payment is by card, by crypto (with a 5% discount), or on delivery. Every vial ships with the certificate of analysis (COA) for its exact batch.
Source / documentationShare your experience
No reviews yet. Tell others what you think of this product.
SLU-PP-915 is a second-generation "exercise mimetic": a small synthetic molecule (not a peptide) that switches on the ERR receptors — the internal toggles that launch the aerobic-training programme in muscles. It was developed at Saint Louis University, in the same programme as SLU-PP-332.
Why a separate molecule was needed: SLU-PP-332 breaks down quickly in the body, so studies administered it by injection. The 915 compound is chemically different — a different scaffold, with a boronic-acid fragment — and markedly more stable: for the first time in this series, the compound can be taken by mouth, so it needs no injection. It is not a "new version" of the 332 — it is a substance in its own right.
What the studies showed: in mice, oral SLU-PP-915 increased running endurance about as much as injected SLU-PP-332 (Billon et al., Journal of Pharmacology and Experimental Therapeutics, 2026) and switched on the same "training" programme in muscles. Honestly about the limits: all published data are in mice only; there have been no human studies yet.
How it is used in research: by mouth. Our guide lists these regimens: start at 1 mg a day, titration at 1–2 mg, and an upper range of 2–3 mg a day, which can be split into two doses. These summarise preclinical work — they are not a clinical regimen. Details are in the dosing guide on this page. Shelf neighbours: its injected predecessor SLU-PP-332 and the peptide "mimetic" MOTS-c, which works through the AMPK enzyme.
Every batch is purity-tested by HPLC, and the certificate of analysis (COA) for your exact batch is in our COA archive. Store in a dry, dark place at a low temperature. The scientific details — chemistry, the ERR receptors and the primary sources — are in the SLU-PP-915 monograph in our wiki.